Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline
Categorie
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Les marques, Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Analogs
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Les marques melange
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Formule chimique
C26H35N8O18P2
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline RX lien
No information avaliable
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline FDA fiche
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline msds (fiche de securite des materiaux)
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Synthese de reference
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Poids moleculaire
809.553 g/mol
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Point de fusion
No information avaliable
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline H2O Solubilite
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Etat
Solid
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline LogP
No information avaliable
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Formes pharmaceutiques
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Indication
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Pharmacologie
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Absorption
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Toxicite
Aucune information disponible
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Information pour les patients
No information avaliable
Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline Organismes affectes
Aucune information disponible
